ArticleJCI insight2022
IL-6-targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function.
Cate Speake et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papertrialcites it